SILVER SPRING, Md., Sept. 20, 2023 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that Dr. Randy Mills, President and Chief Executive Officer, will participate on a panel at the Cantor Global Healthcare Conference. The panel discussion will take place in New…Read More
Related Posts
Acumen Pharmaceuticals to Report Third Quarter Financial Results on November 13 2023
CHARLOTTESVILLE, VA. and INDIANAPOLIS, IN., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) ("Acumen" or the "Company"), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets…
Recursion to Participate in Upcoming Investor Conferences Recursion Pharmaceuticals NASDAQRXRX
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion RXRX, a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor…
BIOTECHNE CELEBRATES MILESTONE WITH MORE THAN 1000 ELLA INSTRUMENTS NOW IN OPERATION MarketScreener
MINNEAPOLIS, April 5, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it that it has reached a significant milestone with more than 1,000 Ella™ automated immunoassay instruments now in…
